ID: ALA176596

Max Phase: Preclinical

Molecular Formula: C12H26N2O

Molecular Weight: 214.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)CCCCCNCCCN(C)C

Standard InChI:  InChI=1S/C12H26N2O/c1-12(15)8-5-4-6-9-13-10-7-11-14(2)3/h13H,4-11H2,1-3H3

Standard InChI Key:  IDGXGMBKVHRAQC-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 214.35Molecular Weight (Monoisotopic): 214.2045AlogP: 1.68#Rotatable Bonds: 10
Polar Surface Area: 32.34Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.34CX LogP: 1.11CX LogD: -2.17
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.56Np Likeness Score: -0.14

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source